	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Net Sales	109.29	123.98	136.75	141.97	151.69
Operating Expenses +	89.45	96.73	106.38	108.85	111.3
Raw Material	26.91	33.72	31.67	30.8	29.77
Increase Decrease in Cost	3.18	-2.28	1.34	-0.39	-0.12
Other Manufacturing Expense	0.34	0.63	0.8	0.73	0
Employee Cost	32.38	36.49	38.81	42.49	45.54
Miscellaneous Expenses	66.9	72.13	74.86	80.04	78.63
Operating Profit	19.84	27.25	30.37	33.12	40.39
Other Income	4.31	4.95	5.12	4.67	6.72
Depreciation	2.04	1.9	2.26	2.34	2.73
Interest	0.47	0.43	0.37	0.27	0.45
Profit before tax and exceptio..	21.64	29.87	32.86	35.18	43.93
Exceptional Items	0	0	0	0	0
PBT	21.64	29.87	32.86	35.18	43.93
Provision for Taxation	5.14	7.57	8.26	9.2	11.87
Net Profit	16.5	22.3	24.61	25.98	32.06
NET Profit after MI	0	0	0	0	0
EPS	35.96	48.58	53.9	58.86	72.65
Operating Profit Margin (%)	18.15	21.98	22.21	23.33	26.63
Net Profit Margin (%)	15.1	17.99	18	18.3	21.14

Jenburkt Pharmaceuticals Ltd. Shareholding

Promoter

All Data in Percentage (%)

	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24
Promoter	46.70	46.70	46.70	46.70	47.20
FII	0.00	0.00	0.00	0.00	0.00
MF	0.00	0.00	0.00	0.00	0.00
Others	0.10	0.10	0.00	0.00	0.00

Promoter Non-Promoter